benefits of tirzepatide for weight loss Study sees potential obesity drug in tackling type 2 diabetes The benefits speak for themselves

Manufacturer programs now target uninsured patients

Donald Vollmer Body Works Franklin & Nolensville, TN A 2025 review published in PubMed found that while GLP-1 receptor agonists are effective in reducing fat mass, up to 40% of total weight lost can come from fat-free mass

(CNN) A class-action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lillys blockbuster GLP-1 drug to treat obesity

Tuesday: Breakfast Avocado toast with scrambled eggs and cherry tomatoes

Pharmacogenetics of the Glucagon-like Peptide-1 Receptor Agonist Liraglutide: A Step Towards Personalized Type 2 Diabetes Management

Place the pen directly into an FDA-approved Wegovy disposal sharps container